Cargando…

Safety and immunogenicity of ETVAX®, an oral inactivated vaccine against enterotoxigenic Escherichia coli diarrhoea: a double-blinded, randomized, placebo-controlled trial amongst Finnish travellers to Benin, West Africa

BACKGROUND: No licensed human vaccines are available against enterotoxigenic Escherichia coli (ETEC), a major diarrhoeal pathogen affecting children in low- and middle-income countries and foreign travellers alike. ETVAX®, a multivalent oral whole-cell vaccine containing four inactivated ETEC strain...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kantele, Anu, Riekkinen, Marianna, Jokiranta, T Sakari, Pakkanen, Sari H, Pietilä, Jukka-Pekka, Patjas, Anu, Eriksson, Mari, Khawaja, Tamim, Klemets, Peter, Marttinen, Kati, Siikamäki, Heli, Lundgren, Anna, Holmgren, Jan, Lissmats, Agneta, Carlin, Nils, Svennerholm, Ann-Mari
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2023
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10658657/ https://www.ncbi.nlm.nih.gov/pubmed/37099803 http://dx.doi.org/10.1093/jtm/taad045

Ejemplares similares

Dientamoeba fragilis – the most common intestinal protozoan in the Helsinki Metropolitan Area, Finland, 2007 to 2017
por: Pietilä, Jukka-Pekka, et al.
Publicado: (2019)

Travelers’ health problems and behavior: prospective study with post-travel follow-up
por: Vilkman, Katri, et al.
Publicado: (2016)

Safety and immunogenicity of the oral, inactivated, enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi children and infants: a double-blind, randomised, placebo-controlled phase 1/2 trial
por: Qadri, Firdausi, et al.
Publicado: (2020)

Imported malaria in Finland 2003-2011: prospective nationwide data with rechecked background information
por: Siikamäki, Heli, et al.
Publicado: (2013)

High number of diarrhoeal co-infections in travellers to Benin, West Africa
por: Lääveri, Tinja, et al.
Publicado: (2014)

From cholera to enterotoxigenic Escherichia coli (ETEC) vaccine development
por: Svennerholm, Ann-Mari
Publicado: (2011)

Monkey Malaria in a European Traveler Returning from Malaysia
por: Kantele, Anu, et al.
Publicado: (2008)

European hospitals as source of multidrug-resistant bacteria: analysis of travellers screened in Finland after hospitalization abroad
por: Kajova, Mikael, et al.
Publicado: (2022)

Evaluation of the safety and immunogenicity of the oral inactivated multivalent enterotoxigenic Escherichia coli vaccine ETVAX in Bangladeshi adults in a double-blind, randomized, placebo-controlled Phase I trial using electrochemiluminescence and ELISA assays for immunogenicity analyses
por: Akhtar, Marjahan, et al.
Publicado: (2019)

Mucosal Immune Responses Against an Oral Enterotoxigenic Escherichia coli Vaccine Evaluated in Clinical Trials
por: Svennerholm, Ann-Mari, et al.
Publicado: (2021)

Fatal Babesiosis in Man, Finland, 2004
por: Haapasalo, Karita, et al.
Publicado: (2010)

Kinetics of Neutralizing Antibodies of COVID-19 Patients Tested Using Clinical D614G, B.1.1.7, and B 1.351 Isolates in Microneutralization Assays
por: Virtanen, Jenni, et al.
Publicado: (2021)

Superspreading of SARS-CoV-2 Omicron BA.2.23 among vaccinated Finnish adults: symptomatic COVID-19 only contracted by those without recent infection
por: Riekkinen, Marianna, et al.
Publicado: (2023)

Characterization of low-density granulocytes in COVID-19
por: Cabrera, Luz E., et al.
Publicado: (2021)

Scent dogs in detection of COVID-19: triple-blinded randomised trial and operational real-life screening in airport setting
por: Kantele, Anu, et al.
Publicado: (2022)

Head-to-Head Comparison of Humoral Immune Responses to Vi Capsular Polysaccharide and Salmonella Typhi Ty21a Typhoid Vaccines–A Randomized Trial
por: Kantele, Anu, et al.
Publicado: (2013)

Import of multidrug-resistant bacteria from abroad through interhospital transfers, Finland, 2010–2019
por: Kajova, Mikael, et al.
Publicado: (2021)

Enterotoxigenic Escherichia coli Multilocus Sequence Types in Guatemala and Mexico
por: Nicklasson, Matilda, et al.
Publicado: (2010)

Sulfatide Recognition by Colonization Factor Antigen CS6 from Enterotoxigenic Escherichia coli
por: Jansson, Lena, et al.
Publicado: (2009)

SARS-CoV-2 infections among healthcare workers at Helsinki University Hospital, Finland, spring 2020: Serosurvey, symptoms and risk factors
por: Kantele, Anu, et al.
Publicado: (2021)

Pathogen-Specific Circulating Plasmablasts in Patients with Pneumonia
por: Palkola, Nina V., et al.
Publicado: (2012)

Immune Defense in Upper Airways: A Single-Cell Study of Pathogen-Specific Plasmablasts and Their Migratory Potentials in Acute Sinusitis and Tonsillitis
por: Palkola, Nina V., et al.
Publicado: (2016)

Differences in Homing Potentials of Streptococcus pneumoniae–Specific Plasmablasts in Pneumococcal Pneumonia and After Pneumococcal Polysaccharide and Pneumococcal Conjugate Vaccinations
por: Palkola, Nina V., et al.
Publicado: (2015)

Oral inactivated whole cell vaccine for mucosal immunization: ETVAX case study
por: Walker, Richard I., et al.
Publicado: (2023)

FUT2 non-secretor status is associated with altered susceptibility to symptomatic enterotoxigenic Escherichia coli infection in Bangladeshis
por: Mottram, Lynda, et al.
Publicado: (2017)

Author Correction: FUT2 non-secretor status is associated with altered susceptibility to symptomatic enterotoxigenic Escherichia coli infection in Bangladeshis
por: Mottram, Lynda, et al.
Publicado: (2018)

Expression of Colonization Factor CS5 of Enterotoxigenic Escherichia coli (ETEC) Is Enhanced In Vivo and by the Bile Component Na Glycocholate Hydrate
por: Nicklasson, Matilda, et al.
Publicado: (2012)

Shift in Phenotypic Characteristics of Enterotoxigenic Escherichia coli (ETEC) Isolated from Diarrheal Patients in Bangladesh
por: Begum, Yasmin Ara, et al.
Publicado: (2014)

Enterotoxigenic Escherichia coli and Vibrio cholerae Diarrhea, Bangladesh, 2004
por: Qadri, Firdausi, et al.
Publicado: (2005)

Glyco-engineered cell line and computational docking studies reveals enterotoxigenic Escherichia coli CFA/I fimbriae bind to Lewis a glycans
por: Mottram, Lynda, et al.
Publicado: (2018)

Treatment of Dientamoeba fragilis: A retrospective Finnish analysis of faecal clearance and clinical cure comparing four antiprotozoal drugs
por: Pietilä, Jukka-Pekka, et al.
Publicado: (2023)

Immunosuppression Adversely Affects TST but Not IGRAs in Patients with Psoriasis or Inflammatory Musculoskeletal Diseases
por: Tavast, Esko, et al.
Publicado: (2012)

T-helper Cell-Mediated Proliferation and Cytokine Responses against Recombinant Merkel Cell Polyomavirus-Like Particles
por: Kumar, Arun, et al.
Publicado: (2011)

Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC)
por: von Mentzer, Astrid, et al.
Publicado: (2017)

Reactive arthritis and other musculoskeletal symptoms associated with acquisition of diarrhoeagenic Escherichia coli (DEC)
por: Tuompo, Riitta, et al.
Publicado: (2020)

Publisher Correction: Identification and characterization of the novel colonization factor CS30 based on whole genome sequencing in enterotoxigenic Escherichia coli (ETEC)
por: von Mentzer, Astrid, et al.
Publicado: (2018)

Persistence of Diarrheal Pathogens Is Associated with Continued Recruitment of Plasmablasts in the Circulation
por: Kantele, Anu
Publicado: (2012)

As Far as Travelers' Risk of Acquiring Resistant Intestinal Microbes Is Considered, No Antibiotics (Absorbable or Nonabsorbable) Are Safe
por: Kantele, Anu
Publicado: (2015)

Travellers as sentinels of chikungunya epidemics: a family cluster among Finnish travellers to Koh Lanta, Thailand, January 2019
por: Kantele, Anu
Publicado: (2019)

Author’s response: False-positive results with rapid diagnostic test for dengue in Thailand
por: Kantele, Anu
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_r11gqkku9kqbtfunmm3jgha6ht